| Neoadjuvant Bleomycin, Etoposide, and Cisplatin (BEP) Chemotherapy in the Treatment of Extensively Advanced Yolk Sac Tumors: A Single Center Experience | |
| Zhang, Gong-yi; Zhang, Rong; Wu, Ling-ying; Li, Bin; Li, Shu-min | |
| 2018 | |
| 卷号 | 28期号:4页码:713-720 |
| 关键词 | Endodermal Sinus Tumor Neoadjuvant Therapy Bleomycin Etoposide Cisplatin Cytoreduction Survival |
| ISSN号 | 1048-891X |
| DOI | 10.1097/IGC.0000000000001209 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6360601 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Zhang, Gong-yi,Zhang, Rong,Wu, Ling-ying,et al. Neoadjuvant Bleomycin, Etoposide, and Cisplatin (BEP) Chemotherapy in the Treatment of Extensively Advanced Yolk Sac Tumors: A Single Center Experience[J],2018,28(4):713-720. |
| APA | Zhang, Gong-yi,Zhang, Rong,Wu, Ling-ying,Li, Bin,&Li, Shu-min.(2018).Neoadjuvant Bleomycin, Etoposide, and Cisplatin (BEP) Chemotherapy in the Treatment of Extensively Advanced Yolk Sac Tumors: A Single Center Experience.,28(4),713-720. |
| MLA | Zhang, Gong-yi,et al."Neoadjuvant Bleomycin, Etoposide, and Cisplatin (BEP) Chemotherapy in the Treatment of Extensively Advanced Yolk Sac Tumors: A Single Center Experience".28.4(2018):713-720. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论